24 employees
A leader in precision medicine, the CureMatch Decision Support System helps guide oncologists in the selection of personalized cancer drugs.
2015
CureMatch, Inc. raised undisclosed on October 27, 2017
Investors: Serra Ventures
CureMatch, Inc. raised undisclosed on August 15, 2017